A SAFE note legal review is often treated as a quick check before a founder sends a document for signature. That is understandable: SAFEs are designed to close faster than priced equity rounds. But the document that feels simple at signing can determine dilution, investor rights, and negotiating leverage when the company finally raises a priced round.<\/p>\n
A SAFE is not technically a promissory note. Unlike a convertible note, it generally does not accrue interest or mature on a stated date. It is an agreement for future equity. The legal work is therefore less about repayment mechanics and more about understanding what future equity the company may be committing to issue, on what terms, and alongside which other promises.<\/p>\n
The central question is not whether the SAFE is based on a familiar market form. It is whether the document works for this company, this financing plan, and this investor group.<\/p>\n
Counsel should start by identifying the SAFE type. A post-money valuation cap SAFE, a pre-money valuation cap SAFE, a discount SAFE, and a most-favored-nation SAFE can produce very different outcomes. A document labeled \u201cstandard\u201d may still contain a side letter, special information rights, pro rata rights, or a customized definition that materially changes the deal.<\/p>\n
The review should also model the result, not just read the words. Founders need to see how the SAFE converts in plausible financing scenarios: a strong next round, a modest round, a down round, an acquisition before conversion, or no financing for longer than expected. A valuation cap can look generous in isolation but become expensive when multiple SAFEs stack up before a priced round.<\/p>\n
This is particularly true with post-money SAFEs. Their economic appeal is certainty for an individual investor: the investor can better understand the percentage ownership associated with their investment. For the company, however, issuing several post-money SAFEs without a complete capitalization model can create more dilution than the founders expected. The trade-off is not inherently bad. It should be deliberate.<\/p>\n
The valuation cap is usually the term founders focus on first, and for good reason. It establishes a ceiling on the valuation used to calculate conversion into preferred stock in a future equity financing. A lower cap generally means more shares for the SAFE holder.<\/p>\n
The discount gives the investor a reduced price per share relative to the new-money investors in the next round. Where both a cap and discount apply, the investor typically receives whichever calculation produces the better conversion result. That interaction needs to be checked against the company\u2019s financing assumptions, not simply accepted because it appears in a template.<\/p>\n
The legal definition of the relevant company capitalization also matters. Small drafting differences regarding option pools, issued shares, reserved shares, and other convertible instruments can move the economics. A cap is only as clear as the capitalization definition supporting it.<\/p>\n
Most SAFEs convert when the company completes an equity financing that meets a stated threshold. Review whether that threshold is commercially realistic. If it is too high, a smaller but meaningful institutional financing may not trigger automatic conversion. If it is too low, a modest financing could trigger conversion before the company has the capital needed to support the resulting preferred stock structure.<\/p>\n
Counsel should also review which shares the SAFE converts into and whether the SAFE holder receives the same preferred stock sold in the financing or a shadow series with tailored economics. These points can affect voting, protective provisions, dividends, and treatment in a sale of the company.<\/p>\n
A SAFE is not only about the next venture round. It should define what happens if the company is acquired, completes another liquidity transaction, winds down, or dissolves before conversion.<\/p>\n
In a liquidity event, the holder may be entitled to receive a cash payment or the value they would receive on an as-converted basis, depending on the document and transaction. In a dissolution event, SAFE holders may have a priority claim ahead of common stockholders but behind creditors. The exact hierarchy matters, especially for companies with debt, grants, commercial obligations, or a more complex capitalization table.<\/p>\n
These provisions are often short. They can still determine who participates in value and how much when the company\u2019s future does not follow the expected financing path.<\/p>\n
The SAFE itself may be clean while a side letter changes the practical deal. Side letters can grant pro rata rights, information rights, board observer access, consultation rights, special notice rights, or rights to participate in future financings.<\/p>\n
One investor receiving a tailored right may be manageable. Repeating that promise across a broad syndicate can create an administrative burden or complicate a later lead investor\u2019s terms. The company should track every side letter in one place and confirm that new rights do not conflict with rights already granted.<\/p>\n
Most-favored-nation provisions require particular care. If a later SAFE is issued on more favorable terms, an MFN holder may have the ability to adopt some or all of those terms. The scope of that election, and any exceptions, should be understood before the company issues the next SAFE.<\/p>\n
A SAFE financing is still a securities transaction. The company needs appropriate corporate authorization, accurate records, and a valid exemption from registration under U.S. federal and applicable state securities laws. The required analysis depends on how the offering is conducted, who receives the SAFE, what representations are collected, and whether any general solicitation occurs.<\/p>\n
A legal review should confirm the company\u2019s governing documents and approval process. Depending on the entity and its documents, this may include board consent, stockholder action, and a review of existing investor consent rights. Companies that raised prior preferred equity may have protective provisions that limit new financing activity or require specified approvals.<\/p>\n
For non-U.S. founders or investors, the analysis can extend beyond the SAFE form. The company may need to consider sanctions and know-your-customer concerns, foreign exchange restrictions, local tax consequences, investor eligibility, and whether foreign ownership creates industry-specific or regulatory issues. A U.S. Delaware corporation with a global cap table is common, but it is not a reason to assume every investor can be treated identically.<\/p>\n
Tax should also be considered early enough to avoid false expectations. For example, founders sometimes assume a SAFE starts the holding period for qualified small business stock treatment. In many cases, the relevant equity is issued only upon conversion, which may affect the timing analysis. Tax outcomes are fact-specific and warrant advice from qualified tax counsel.<\/p>\n
Routine documents can benefit from technology-assisted intake, cap table organization, and issue spotting. Those tools reduce friction and help teams move faster. They do not replace legal judgment on bespoke economics, securities-law compliance, investor rights, or a financing strategy that will shape the next round.<\/p>\n
Attorney involvement is particularly valuable when the company is issuing more than one SAFE, negotiating a cap or discount, accepting institutional capital, offering side rights, or raising from investors outside the United States. It is also prudent where the company has prior financings, outstanding options, debt, multiple founders, or uncertain ownership records.<\/p>\n
A sensible delivery model matches the work to the risk. A straightforward, standardized review may be scoped as a defined fixed-fee project. A company building a financing plan, negotiating side letters, or coordinating a cross-border syndicate may need direct attorney counsel. Lex Padilla uses technology to make routine legal workflows more efficient, while licensed attorneys remain responsible for the legal advice and transaction judgment.<\/p>\n
The fastest legal review is one supported by an organized deal file. Provide the current certificate of incorporation, bylaws, stock ledger or cap table, prior SAFEs and convertible notes, option plan records, prior financing documents, and every draft side letter. If the company has made informal promises about allocations or future investment rights, disclose those too.<\/p>\n
The goal is not paperwork for its own sake. It is to identify commitments that may be invisible in the latest SAFE draft. A cap table can be mathematically accurate and still fail to capture contractual rights that affect the next financing.<\/p>\n
Before accepting capital, founders should be able to state plainly what each investor will receive, what could change in the next round, and what rights the company is granting beyond economics. If those answers are unclear, the documents are not ready simply because the signature page is.<\/p>\n
Please note that this article (1) is not provided in the course of and does not create or constitute an attorney-client relationship, (2) is not intended as solicitation, (3) is not intended to convey or constitute legal advice, and (4) is not a substitute for obtaining legal or tax advice from qualified professionals.<\/em><\/p>","protected":false},"excerpt":{"rendered":" A SAFE note legal review identifies valuation, conversion, governance, and cross-border issues before a fast financing creates surprises for founders.<\/p>","protected":false},"author":1,"featured_media":218,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-217","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/posts\/217","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/comments?post=217"}],"version-history":[{"count":1,"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/posts\/217\/revisions"}],"predecessor-version":[{"id":270,"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/posts\/217\/revisions\/270"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/media\/218"}],"wp:attachment":[{"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/media?parent=217"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/categories?post=217"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lex.padilla.law\/es\/wp-json\/wp\/v2\/tags?post=217"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}